Chronic Ulcer
13
3
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.7%
1 terminated out of 13 trials
87.5%
+1.0% vs benchmark
8%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.
Study of Tolerance to the Application of Cold Plasma in the Treatment of Chronic Wounds
Evaluation of Diaphragmatic Function After Interscalene Block With Liposomal Bupivacaine
A Real-World Registry of Chronic Wounds and Ulcers
A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Population in Specialized Nursing Facilities Using RD1
Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs
Confirm Safety and Performance of Avance Solo and Avance Solo Adapt NPWT Systems
Efficacy of PICO Single-use System in Chronic Ulcers
Unripe Banana Peel Powder and Lemongrass Oil in Chronic Ulcer
Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds
Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers
Electrical Stimulation of Cutaneous Lesions
Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers